参考文献/References:
[1]Quiat D,Kula T,Shimizu C,et al. Unbiased screening of Kawasaki disease sera for viral antigen exposure[J]. Open Forum Infect Dis,2017,4(suppl_1):S684-S685.
[2]Thumjaa A,Selvakumar C. Atypical Kawasaki disease[J]. Harefuah,2017,64(3):100-102.
[3]覃艺玉.川崎病的研究进展[J].临床医药文献电子杂志,2017,4(90):17814-17815.
[4]周倩沁,吴军华,邱海燕. 川崎病病因及发病机制的研究进展[J]. 浙江医学,2019,41(13):1443-1446.
[5] Huang SM, Huang SH, Weng KP,et al. Update on association between Kawasaki disease and infection[J].?J Chin Med Assoc,2019,82(3):172–174.
[6]李瑞燕,李晓辉. 川崎病病因学研究进展 [J]. 心血管病学进展 ,2010,31(4):616-620.
[7]Yamashiro Y,Nagata S,Ohtsuka Y,et al. Microbiologic studies on the small intestine in Kawasaki disease[J]. Pediatr Res,1996,39(4 Pt 1):622-624.
[8]Eladawy M,Dominguez SR ,Anderson MS,et al. Kawasaki disease and the pediatric gastroenterologist:a diagnostic challenge[J]. J Pediatr Gastroenterol Nutr,2013,56(3):297-299.
[9]Esposito S,Polinori I,Rigante D. The gut microbiota-host partnership as a potential driver of Kawasaki syndrome[J]. Front Pediatr,2019,34(7):124-126.
[10]Monedero V,Buesa J,Rodríguez-Díaz J. The interactions between host glycobiology,bacterial microbiota,and viruses in the gut[J]. Viruses,2018,10(2):96.
[11]B?ckhed F,Roswall J,Peng Y,et al. Dynamics and stabilization of the human gut microbiome during the first year of life[J]. Cell Host Microbe,2015,17( 6):852.
[12]Koenig JE,Spor A,Scalfone N,et al. Succession of microbial consortia in the developing infant gut microbiome[J]. Proc Natl Acad Sci U S A ,2011,108 suppl 1(suppl 1):4578-4585.
[13]Chen SY,Tsai CN,Lee SY,et al. Intestinal microbiome in children with severe and complicated acute viral gastroenteritis[J]. Sci Rep,2017 (7):46130.
[14]Motta JP,Allain T,Green-Harrison LE,et al. Iron sequestration in microbiota biofilms as a novel strategy for treating inflammatory bowel disease[J]. Inflamm Bowel Dis,2018,24(7):1493-1502.
[15]Lee YK,Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system?[J]. Science,2010,330(6012):1768-1773.
[16]Aguilera M,Cerdà-Cuéllar,M,Martínez,V. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice[J]. Gut Microbes,2015,6(1):10-23.
[17]Rigante D,Tarantino G,Valentini P. Non-infectious makers of Kawasaki syndrome:tangible or elusive triggers?[J]. Immunol Res,2016,64(1):51-54.
[18]张胜,梁雪. 川崎病治疗研究进展[J]. 国际儿科学杂志,2018,45(8):584-588.
[19]Rowley,Anne H.The etiology of Kawasaki Disease:A conventional infectious agent[J]. Progress in Pediatric Cardiology ,2004,19(2):109-113.
[20]Bressieux-Degueldre S,Schaffner D,Hofer M,et al. Kawasaki disease:an update[J]. Rev Med Suisse,2018,14(594):384-389.
[21]Nagata S,Yamashiro Y,Ohtsuka Y,et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease[J]. Immunology,2009,128(4):511-520.
[22]Nagata S,Yamashiro Y Maeda M,et al. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease[J]. Pediatr Res,1993,33(6):557-563.
[23]Hooper LV,Wong MH,Thelin A,et al. Molecular analysis of commensal host-microbial relationships in the intestine[J]. Science,2001,291(5505):881-884.
[24]Wang H,Gong J,Wang W,et al. Are There any different effects of Bifidobacterium,Lactobacillus and Streptococcus on intestinal sensation,barrier function and intestinal immunity in PI-IBS mouse model?[J]. PLoS One,2014,9(3):e90153.
[25]Reading NC,Kasper DL. The starting lineup:key microbial players in intestinal immunity and homeostasis[J]. Front Microbiol,2011,2:148.
[26]Fernandez EM,Valenti V,Rockel C,et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide[J]. Gut,2011,60(8):1050-1059.
[27]Takeshita S,Kobayashi I,Kawamura Y,et al. Characteristic profile of intestinal microflora in Kawasaki disease[J]. Acta Paediatr,2002,91(7):783-788.
[28]Takeshita S,Tsujimoto H,Kawase H,et al. Increased levels of lipopolysaccharide binding protein in plasma in children with kawasaki disease[J]. Clin Diagn Lab Immunol,2002,9(1):205-206.
[29]Nagata S,Yamashiro Y,Ohtsuka Y,et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease[J]. Immunology,2009,128(4):511-520.
[30]沈男,刘毅,盖中涛. 肠道菌群与肠道疾病关系的研究进展[J]. 基础医学与临床,2018,38(7):1034-1037.
[31]Sobhonslidsuk A,Chanprasertyothin S,Pongrujikorn T,et al. The association of gut microbiota with nonalcoholic steatohepatitis in Thais[J]. Biomed Res Int,2018,2018:9340316.
[32]王晨,钟赛意,邹宇晓. 膳食纤维经肠道微生态途径调节脂质代谢作用的研究进展[J]. 食品科学,2019,40(3):347-356..
[33]Motta JP,Allain T,Green-Harrison LE,et al. Iron sequestration in microbiota biofilms as a novel strategy for treating inflammatory bowel disease[J]. Inflamm Bowel Dis,2018,24(7):1493-1502.
[34]Tyagi AM,Yu M,Darby TM,et al. The microbial metabolite butyrate stimulates bone formation via t regulatory cell-mediated regulation of WNT10B expression[J]. Immunity,2018,49(6):1116–1131.e7.
[35]吴少辉,魏远安,吴嘉仪,等.益生元精准化研究进展[J].食品科学,2018,39(9):333-340.
[36]Barratt MJ,Lebrilla C,Shapiro HY,et al. The gut microbiota,food science,and human nutrition:a timely marriage[J]. Cell Host Microbe,2017,22(2):134-141.
[37]张庆,李晓静. 川崎病的治疗现状[J]. 心血管病学进展 ,2010,31(5):766-769.
[38]Hedrich CM,Schnabel A,Hospach T. Kawasaki disease[J]. Front Pediatr,2018,6:198.